Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Accumulated Expenses (2020 - 2025)

Sotera Health (SHC) has 6 years of Accumulated Expenses data on record, last reported at $124.7 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 37.89% year-over-year to $124.7 million; the TTM value through Dec 2025 reached $124.7 million, up 37.89%, while the annual FY2025 figure was $124.7 million, 37.89% up from the prior year.
  • Accumulated Expenses reached $124.7 million in Q4 2025 per SHC's latest filing, down from $139.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $496.8 million in Q1 2023 and bottomed at $52.7 million in Q2 2022.
  • Average Accumulated Expenses over 5 years is $127.2 million, with a median of $86.7 million recorded in 2024.
  • Peak YoY movement for Accumulated Expenses: soared 721.7% in 2023, then plummeted 87.57% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $61.9 million in 2021, then surged by 692.31% to $490.1 million in 2022, then crashed by 75.01% to $122.5 million in 2023, then decreased by 26.14% to $90.5 million in 2024, then surged by 37.89% to $124.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $124.7 million in Q4 2025, $139.7 million in Q3 2025, and $143.5 million in Q2 2025.